|
MED13L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53072999999893E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.81110000330165E-08 |
| Normal-vs-Stage2 |
7.744300E-03 |
| Normal-vs-Stage3 |
1.427800E-01 |
| Normal-vs-Stage4 |
7.398000E-01 |
| Stage1-vs-Stage2 |
8.310000E-01 |
| Stage1-vs-Stage3 |
3.243700E-03 |
| Stage1-vs-Stage4 |
3.83499999978554E-07 |
| Stage2-vs-Stage3 |
7.179700E-02 |
| Stage2-vs-Stage4 |
6.597600E-03 |
| Stage3-vs-Stage4 |
1.172360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63501000000066E-05 |
| Normal-vs-AfricanAmerican |
1.247570E-01 |
| Normal-vs-Asian |
3.733600E-01 |
| Caucasian-vs-AfricanAmerican |
6.581400E-01 |
| Caucasian-vs-Asian |
9.273200E-01 |
| AfricanAmerican-vs-Asian |
8.270400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.237250E-04 |
| Normal-vs-Female |
1.802710E-04 |
| Male-vs-Female |
6.130600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.512800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.4256999999972E-05 |
| Normal-vs-Age(61-80Yrs) |
4.951500E-04 |
| Normal-vs-Age(81-100Yrs) |
5.898200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.849600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.151600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.772400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.932000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.413800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.820000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.202100E-03 |
| Normal-vs-Grade 2 |
8.08739997193442E-09 |
| Normal-vs-Grade 3 |
2.231500E-02 |
| Normal-vs-Grade 4 |
5.223000E-01 |
| Grade 1-vs-Grade 2 |
1.155840E-01 |
| Grade 1-vs-Grade 3 |
2.171800E-02 |
| Grade 1-vs-Grade 4 |
7.88000000000455E-05 |
| Grade 2-vs-Grade 3 |
2.019400E-04 |
| Grade 2-vs-Grade 4 |
8.54060000055057E-07 |
| Grade 3-vs-Grade 4 |
2.376400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.95500323999454E-11 |
| Normal-vs-ccB subtype |
3.052300E-02 |
| ccA subtype-vs-ccB subtype |
1.641090E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.811100E-04 |
| Normal-vs-N1 |
9.178800E-01 |
| N0-vs-N1 |
1.885370E-01 |
|
|
